"The right Medicare coverage protects your health and your peace of mind," said Jeff Fernandez, president of Aetna Medicare. "Our 2027 plans put our members and their experience at the center, ...

Delaware courts have spent the last several years wrestling with one of the hardest questions in corporate governance law: at what point does a board’s failure to prevent corporate misconduct stop ...

UPDATE: Microsoft has said it's now addressed the issues that caused an Xbox services outage earlier today, bringing players back online. "Great news, everyone! Engineering has confirmed mitigation," ...

If you can’t sign in to a Microsoft account on Windows 11, try the solutions below. One of the most common reasons for a login failure is a credential mismatch, which happens when the provided ...

Google Search is testing asking searchers to sign in to verify they are humans and not bots conducting the searches. I don't think Google has done this before, geneally when Google tries to verify ...

The U.S. Federal Trade Commission has finalized its long-awaited settlement with CVS Caremark, offering further clarity on how the agency aims to reshape the pharmacy benefit manager (PBM) industry.

The Federal Trade Commission (FTC) has reached a settlement agreement with CVS Caremark. According to an agency press release, Caremark is one of the biggest pharmacy benefit managers (PBMs) in the ...

The Federal Trade Commission has secured a settlement agreement with Caremark, the pharmacy benefit manager for CVS Health, resolving its lawsuit against the pharmacy benefit manager. The FTC reached ...

A rebate-driven formulary model allegedly incentivized higher insulin list prices, affecting three PBMs controlling roughly 80% of US prescriptions and contributing to cost-related insulin rationing ...

CVS Caremark reached a global settlement to resolve all outstanding litigation and investigations involving CVS Health -- including its pharmacy benefits management and affiliated pharmacy businesses ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...